Mutant Phi29 DNA Polymerase Thermostability and Processivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing bacteriophage phi29 DNA polymerase has limitations due to its relatively low thermostability, which restricts its application in DNA amplification techniques, particularly with high G/C content DNA and at elevated temperatures, leading to slower reaction kinetics and increased formation of non-specific products.
Innovation Solution
Mutations such as E221K, M8R, V51A, M97T, G197D, K209E, E239G, Q497P, K512E, and F526L are introduced into the phi29 DNA polymerase to enhance its thermostability, processivity, and fidelity, allowing for more efficient DNA amplification at higher temperatures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If phi29 DNA polymerase is used at elevated temperatures to improve reaction kinetics, then DNA amplification efficiency increases, but the enzyme's thermostability is insufficient leading to reduced enzyme stability
Solution Approach 1:
The patent applies parameter changes by modifying amino acid residues at specific positions (e.g., E221K, M8R, V51A, M97T, G197D, K209E, E239G, Q497P, K512E, F526L) to alter the enzyme's physical-chemical properties. These mutations increase thermostability while preserving catalytic activity, enabling the enzyme to function effectively at elevated temperatures up to 40°C and beyond, thus resolving the contradiction between reaction kinetics and enzyme stability
2Adaptability or versatility
If phi29 DNA polymerase is used for DNA amplification with high G/C content, then amplification of difficult templates is achieved, but non-specific product formation increases due to low reaction temperature
Solution Approach 1:
The mutated phi29 DNA polymerase exhibits enhanced thermostability that enables reactions at elevated temperatures (up to 40°C and higher). This temperature increase improves the specificity of DNA amplification by reducing non-specific product formation, while the enzyme's modified structure maintains its ability to handle high G/C content templates effectively
3Reliability
If wild-type phi29 DNA polymerase is used at 30°C optimal temperature, then enzyme stability is maintained, but reaction kinetics are slower
Solution Approach 1:
The patent introduces multiple amino acid mutations that collectively enhance the enzyme's thermostability parameters. This allows the enzyme to maintain stability at higher temperatures where reaction kinetics are inherently faster, thus resolving the trade-off between stability at low temperature and speed at high temperature
4Manufacturing precision
If phi29 DNA polymerase is used for whole genome amplification, then complete genome coverage is achieved, but amplification bias occurs due to processivity limitations
Solution Approach 1:
The mutations in phi29 DNA polymerase enhance processivity by improving the enzyme's ability to remain bound to DNA during synthesis. This increased processivity reduces amplification bias and improves genome coverage completeness while simultaneously enhancing overall amplification efficiency and speed
Data Source
Figure 1
Figure 2
Figure 2
AI summary
Mutants of bacteriophage phi29 DNA polymerase with increased protein stability and increased half-life, compared to wild type DNA polymerase. The disclosed mutants are more stable in reaction mixtures with or without DNA. The inventive phi29 DNA polymerase mutants generate more amplification product. The inventive phi29 DNA polymerase mutants amplify genomic DNA with less bias compared to wild type DNA polymerase. Selected mutations increase the affinity of polymerase for DNA template.